These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 27270894

  • 1. Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone.
    Lawres LA, Garg A, Kumar V, Bruzual I, Forquer IP, Renard I, Virji AZ, Boulard P, Rodriguez EX, Allen AJ, Pou S, Wegmann KW, Winter RW, Nilsen A, Mao J, Preston DA, Belperron AA, Bockenstedt LK, Hinrichs DJ, Riscoe MK, Doggett JS, Ben Mamoun C.
    J Exp Med; 2016 Jun 27; 213(7):1307-18. PubMed ID: 27270894
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of Two New Endochin-like Quinolones, ELQ-596 and ELQ-650, in Experimental Mouse Models of Human Babesiosis.
    Vydyam P, Chand M, Pou S, Winter RW, Liebman KM, Nilsen A, Doggett JS, Riscoe MK, Ben Mamoun C.
    ACS Infect Dis; 2024 Apr 12; 10(4):1405-1413. PubMed ID: 38563132
    [Abstract] [Full Text] [Related]

  • 3. Effective Therapy Targeting Cytochrome bc1 Prevents Babesia Erythrocytic Development and Protects from Lethal Infection.
    Chiu JE, Renard I, Pal AC, Singh P, Vydyam P, Thekkiniath J, Kumar M, Gihaz S, Pou S, Winter RW, Dodean R, Frueh L, Nilsen AC, Riscoe MK, Doggett JS, Mamoun CB.
    Antimicrob Agents Chemother; 2021 Aug 17; 65(9):e0066221. PubMed ID: 34152821
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combination of Clofazimine and Atovaquone as a Potent Therapeutic Regimen for the Radical Cure of Babesia microti Infection in Immunocompromised Hosts.
    Tuvshintulga B, Sivakumar T, Nugraha AB, Ahedor B, Batmagnai E, Otgonsuren D, Liu M, Xuan X, Igarashi I, Yokoyama N.
    J Infect Dis; 2022 Jan 18; 225(2):238-242. PubMed ID: 34664651
    [Abstract] [Full Text] [Related]

  • 7. Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection.
    Wormser GP, Prasad A, Neuhaus E, Joshi S, Nowakowski J, Nelson J, Mittleman A, Aguero-Rosenfeld M, Topal J, Krause PJ.
    Clin Infect Dis; 2010 Feb 01; 50(3):381-6. PubMed ID: 20047477
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tafenoquine-Atovaquone Combination Achieves Radical Cure and Confers Sterile Immunity in Experimental Models of Human Babesiosis.
    Vydyam P, Pal AC, Renard I, Chand M, Kumari V, Gennaro JC, Mamoun CB.
    J Infect Dis; 2024 Jan 12; 229(1):161-172. PubMed ID: 38169301
    [Abstract] [Full Text] [Related]

  • 10. Treatment of Human Babesiosis: Then and Now.
    Renard I, Ben Mamoun C.
    Pathogens; 2021 Sep 01; 10(9):. PubMed ID: 34578153
    [Abstract] [Full Text] [Related]

  • 11. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc1 and Identifies ELQ-400 as a Remarkably Effective Compound against Acute Experimental Toxoplasmosis.
    McConnell EV, Bruzual I, Pou S, Winter R, Dodean RA, Smilkstein MJ, Krollenbrock A, Nilsen A, Zakharov LN, Riscoe MK, Doggett JS.
    ACS Infect Dis; 2018 Nov 09; 4(11):1574-1584. PubMed ID: 30117728
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Babesiosis in humans: a treatment review.
    Weiss LM.
    Expert Opin Pharmacother; 2002 Aug 09; 3(8):1109-15. PubMed ID: 12150690
    [Abstract] [Full Text] [Related]

  • 17. Atovaquone in the treatment of Babesia microti infections in hamsters.
    Wittner M, Lederman J, Tanowitz HB, Rosenbaum GS, Weiss LM.
    Am J Trop Med Hyg; 1996 Aug 09; 55(2):219-22. PubMed ID: 8780464
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.